Optimisation of embryonic and larval ECG measurement in zebrafish for quantifying the effect of QT prolonging drugs.
Effective chemical compound toxicity screening is of paramount importance for safe cardiac drug development. Using mammals in preliminary screening for detection of cardiac dysfunction by electrocardiography (ECG) is costly and requires a large number of animals. Alternatively, zebrafish embryos can...
Guardado en:
Autores principales: | Sundeep Singh Dhillon, Eva Dóró, István Magyary, Stuart Egginton, Attila Sík, Ferenc Müller |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/45d5c1deb1fc497ab75c5805542b1a35 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Absence of relevant QT interval prolongation in not critically ill COVID-19 patients
por: Juan Jiménez-Jáimez, et al.
Publicado: (2020) -
Embryonic and larval development of Dissostichus eleginoides (Pisces: Nototheniidae)
por: Mujica,Armando, et al.
Publicado: (2016) -
Optogenetic axon guidance in embryonic zebrafish
por: James M. Harris, et al.
Publicado: (2021) -
Transgenerational inheritance of impaired larval T cell development in zebrafish
por: Norimasa Iwanami, et al.
Publicado: (2020) -
British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication
por: Pier D Lambiase, et al.
Publicado: (2019)